• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemia.

作者信息

Ehninger G, Fackler-Schwalbe E, Freund M, Heil G, Henke M, Hoelzer D, Hoffmann R, Kurrle E, Link H, Lösch A

机构信息

Department of Internal Medicine, University of Tübingen, FRG.

出版信息

Haematol Blood Transfus. 1990;33:316-7. doi: 10.1007/978-3-642-74643-7_58.

DOI:10.1007/978-3-642-74643-7_58
PMID:2182425
Abstract
摘要

相似文献

1
Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemia.米托蒽醌与依托泊苷联合用于60岁以上未经治疗的急性髓性白血病患者。
Haematol Blood Transfus. 1990;33:316-7. doi: 10.1007/978-3-642-74643-7_58.
2
Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemia.米托蒽醌与依托泊苷用于复发和难治性急性非淋巴细胞白血病患者
Haematol Blood Transfus. 1990;33:326-9. doi: 10.1007/978-3-642-74643-7_61.
3
Etoposide: fifteen years experience.
Bone Marrow Transplant. 1989 Jan;4 Suppl 1:52-5.
4
Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.
Haematol Blood Transfus. 1990;33:304-8. doi: 10.1007/978-3-642-74643-7_55.
5
Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience.鞘内化疗与骨髓单核细胞性急性髓系白血病的脑膜复发。单中心经验。
Am J Hematol. 2010 Mar;85(3):219. doi: 10.1002/ajh.21606.
6
Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy.
Ann Hematol. 2011 Jun;90(6):733-5. doi: 10.1007/s00277-010-1076-0. Epub 2010 Sep 21.
7
MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemia.米托蒽醌、依托泊苷和中剂量阿糖胞苷（MEC）：一种用于既往未治疗的急性非淋巴细胞白血病的有效诱导方案。
Leuk Lymphoma. 1995 Nov;19(5-6):447-51. doi: 10.3109/10428199509112203.
8
Pharmacokinetics of mitoxantrone, etoposide and cytosine arabinoside in leukemic cells during treatment of acute myelogenous leukemia--relationship to treatment outcome and bone marrow toxicity.米托蒽醌、依托泊苷和阿糖胞苷在急性髓性白血病治疗期间白血病细胞中的药代动力学——与治疗结果和骨髓毒性的关系
Leuk Res. 1995 Oct;19(10):757-61. doi: 10.1016/0145-2126(95)00061-r.
9
Combination therapy with mitoxantrone and etoposide in adult acute myelogenous leukemia.米托蒽醌与依托泊苷联合治疗成人急性髓系白血病。
Haematol Blood Transfus. 1990;33:314-5. doi: 10.1007/978-3-642-74643-7_57.
10
Consolidation therapy with high-dose cytosine arabinoside: experiences of a prospective study in acute myeloid leukemia.
Haematol Blood Transfus. 1990;33:254-60. doi: 10.1007/978-3-642-74643-7_46.

引用本文的文献

1
Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia.米托蒽醌：其药理特性及在急性非淋巴细胞白血病中的应用综述
Drugs Aging. 1996 Aug;9(2):122-47. doi: 10.2165/00002512-199609020-00007.
2
Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.米托蒽醌。对其药效学和药代动力学特性以及在癌症化疗中的治疗潜力的综述。
Drugs. 1991 Mar;41(3):400-49. doi: 10.2165/00003495-199141030-00007.